Truveta data drawn from records covering more than 130 million patients found that nearly 8 of every 100 prescriptions filled in March 2026 were for GLP-1 receptor agonists, described as the largest quarter-over-quarter increase since tracking began in 2019
681002 (EU-ToxRisk) and No
For the scientific community, the future involves: Continued Retatrutide Trials: Monitoring the outcomes of Retatrutide's Phase 3 clinical trials to understand its full efficacy and safety profile as a monotherapy
Most currently available ways to influence this axis, including AMPK activation or mTOR modulation, are systemic and pleiotropic, so their net effects are unlikely to reflect pancreas-specific restoration of mitochondrial quality control alone
ShipBobs model is completely different
Which peptide is better for anti-aging sermorelin or glutathione? This question assumes anti-aging has a single biological target, which it doesnt